CollabRx to Present at the LD MICRO Sixth Annual Conference

CollabRx to Present at the LD MICRO Sixth Annual Conference

Data Analytics Company Informing Clinical Decisions in Molecular Medicine
Scheduled to Present on December 3, 2013

SAN FRANCISCO, Nov. 20, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX),
a data analytics company focused on informing clinical decision making in
molecular medicine, announces that Thomas R. Mika, Chief Executive Officer,
will present at the LD MICRO Sixth Annual Conference at 11 a.m. (PST), Track
1, on December 3, 2013. The conference will be held December 3-5, 2013 at the
Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, California. CollabRx
management will be available during the day on December 3 for one-on-one
meetings. Please contact LD MICRO to schedule a meeting.

About CollabRx

CollabRx, Inc. (CLRX) is a recognized leader in cloud-based expert systems to
inform healthcare decision-making. CollabRx uses information technology to
aggregate and contextualize the world's knowledge on genomics-based medicine
with specific insights from the nation's top cancer experts, starting with the
area of greatest need: advanced cancers in patients who have effectively
exhausted the standard of care. More information may be obtained at


LD MICRO is a by-invitation only newsletter firm that focuses on finding
undervalued companies in the micro-cap space. Since 2002, the firm has
published an annual list of recommended stocks as well as comprehensive
reports on select companies throughout the year. LD MICRO concentrates on
finding, researching, and investing in companies that are overlooked by
institutional investors. It is a non-registered investment advisor. To
register, please call 408-457-1042 or e-mail

CONTACT: Investor Relations Contacts:
         Thomas R. Mika, CEO
         CollabRx, Inc.
         James Carbonara, Regional Vice President
         Hayden IR
         Office: (646)-755-7412

CollabRx, Inc. Logo
Press spacebar to pause and continue. Press esc to stop.